$BBIO 1W — Premium RejectionBridgeBio Pharma, Inc.BATS:BBIOWavervanir_International_LLC🧬 BBIO 1W — Premium Rejection Closed -4.87% at 69.71. Premium ceiling (84.94) rejected. Lost 0.886 + 0.786 fibs. 📐 Structure - Weak High: 84.94 (rejected) - Equilibrium block: 46.18–55.92 (gravity) - Strong Low: 21.61 📉 Downside Map - 66.10 → 60.79 → 53.33 → 46.18 (target) 🔍 Momentum - RSI 51.67 rolling - MA bearish cross - Distribution on the rejection candle 🎯 Invalidation Reclaim 77.73 = breakdown void. Until then, bounces = lower highs. 🧭 Three charts today, one framework: - REI accumulating from discount - FTAI distributing from premium - BBIO distributing from premium Same SMC playbook, different sides of equilibrium. Sector doesn't matter — institutional reference does. Process over prediction. Risk-first, always. NFA. 🤝